Sectors
GALT
Galectin Therapeutics Inc.
3.95
2 x 2.96
1 x 4.07
bid
ask
-
0.07
1.74%
2 @ 07:30 PM
3.95 +0.00 (0.00%)
| Ytd | -5.05% | |
| 1y | -7.71% |
3.91
day range
4.05
2.03
52 week range
7.13
| Open | 4.02 | Prev Close | 4.02 | Low | 3.91 | High | 4.05 | Mkt Cap | 398.36M |
| Vol | 229.71K | Avg Vol | 640.37K | EPS | -0.43 | P/E | N/A | Forward P/E | -0.53 |
| Beta | 0.63 | Short Ratio | 42.37 | Inst. Own | 15.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 3.81 | 200-d Avg | 3.48 | 1yr Est | 11.00 |
| Income Statement | |||
| Operating Expenses | 3.98M | ||
| Research and Development Expense | 2.13M | ||
| Selling, General and Administrative Expense | 1.85M | ||
| Operating Income | -3.98M | ||
| Interest Expense | 2.00M | ||
| Net Income | -9.11M | ||
| Net Income Common Stock | -9.18M | ||
| Net Income Common Stock (USD) | -9.18M | ||
| Consolidated Income | -9.11M | ||
| Earnings per Basic Share | -0.14 | ||
| Earnings per Basic Share (USD) | -0.14 | ||
| Earnings per Diluted Share | -0.14 | ||
| Earning Before Interest & Taxes (EBIT) | -7.11M | ||
| Earning Before Interest & Taxes (USD) | -7.11M | ||
| Preferred Dividends Income Statement Impact | 62.00K | ||
| Weighted Average Shares | 65.88M | ||
| Weighted Average Shares Diluted | 65.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.27M | ||
| Cash and Equivalents (USD) | 13.27M | ||
| Current Assets | 14.66M | ||
| Total Assets | 14.83M | ||
| Debt Current | 137.70M | ||
| Total Debt | 137.70M | ||
| Current Liabilities | 151.62M | ||
| Total Liabilities | 151.68M | ||
| Accumulated Retained Earnings (Deficit) | -446.79M | ||
| Shareholders Equity | -138.57M | ||
| Shareholders Equity (USD) | -138.57M | ||
| Assets Non-Current | 167.00K | ||
| Total Debt (USD) | 137.70M | ||
| Liabilities Non-Current | 59.00K | ||
| Trade and Non-Trade Payables | 3.79M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.00K | ||
| Net Cash Flow from Financing | 1.60M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -842.00K | ||
| Issuance (Purchase) of Equity Shares | 1.60M | ||
| Net Cash Flow from Operations | -2.44M | ||
| Share Based Compensation | 963.00K | ||